Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-10-19 Sale |
2021-10-20 4:14 pm |
Entasis Therapeutics Holdings Inc. | ETTX | Perros Manoussos See Remarks |
11,974 | $3.19 | $38,197 | 147,526 (Direct) |
View |
| 2021-10-19 Sale |
2021-10-20 4:10 pm |
Entasis Therapeutics Holdings Inc. | ETTX | Mueller John Patrick Chief Development Officer |
4,001 | $3.19 | $12,763 | 45,999 (Direct) |
View |
| 2021-10-19 Sale |
2021-10-20 4:09 pm |
Entasis Therapeutics Holdings Inc. | ETTX | Gutch Michael See Remarks |
3,759 | $3.19 | $11,991 | 46,241 (Direct) |
View |
| 2021-10-19 Sale |
2021-10-20 4:08 pm |
Entasis Therapeutics Holdings Inc. | ETTX | Tommasi Ruben Chief Scientific Officer |
3,759 | $3.19 | $11,991 | 68,265 (Direct) |
View |
| 2021-10-19 Sale |
2021-10-20 4:08 pm |
Entasis Therapeutics Holdings Inc. | ETTX | Keiley Elizabeth M General Counsel |
3,759 | $3.19 | $11,991 | 46,241 (Direct) |
View |
| 2021-10-19 Sale |
2021-10-20 4:06 pm |
Entasis Therapeutics Holdings Inc. | ETTX | Altarac David Chief Medical Officer |
3,759 | $3.19 | $11,991 | 46,241 (Direct) |
View |
| 2021-10-19 Sale |
2021-10-20 4:05 pm |
Entasis Therapeutics Holdings Inc. | ETTX | Ronsheim Matthew See Remarks |
3,759 | $3.19 | $11,991 | 46,241 (Direct) |
View |
| 2021-06-11 Purchase |
2021-06-11 5:39 pm |
Entasis Therapeutics Holdings Inc. | ETTX | Innoviva Inc. Innoviva Strategic Opportunities LLC 10% Owner |
6,268,975 | $2 | $12,537,950 | 57,345,794 (Indirect Direct) |
View |
| 2021-05-03 Purchase |
2021-05-20 2:39 pm |
Entasis Therapeutics Holdings Inc. | ETTX | Innoviva Inc. Innoviva Strategic Opportunities LLC 10% Owner |
3,731,025 | $2 | $7,462,050 | 44,807,844 (Indirect Direct) |
View |
| 2020-09-01 Purchase |
2020-09-01 5:31 pm |
Entasis Therapeutics Holdings Inc. | ETTX | Innoviva Inc. 10% Owner |
4,672,897 | $2.675 | $12,499,999 | 37,345,794 (Direct) |
View |
| 2020-06-11 Purchase |
2020-06-12 5:34 pm |
Entasis Therapeutics Holdings Inc. | ETTX | Innoviva Inc. 10% Owner |
12,677,490 | $2.5 | $31,693,725 | 28,000,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-11-02 Tax Withholding |
2021-11-03 4:04 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Keiley Elizabeth M General Counsel |
3,669 | $2.94 | 42,572 (Direct) |
View |
| 2021-11-02 Tax Withholding |
2021-11-03 4:04 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Altarac David Chief Medical Officer |
3,669 | $2.94 | 42,572 (Direct) |
View |
| 2021-11-02 Tax Withholding |
2021-11-03 4:03 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Mueller John Patrick Chief Development Officer |
3,907 | $2.94 | 42,092 (Direct) |
View |
| 2021-11-02 Tax Withholding |
2021-11-03 4:03 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Perros Manoussos President and CEO |
11,704 | $2.94 | 135,822 (Direct) |
View |
| 2021-11-02 Tax Withholding |
2021-11-03 4:02 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Gutch Michael CFO and Chief Business Officer |
3,669 | $2.94 | 42,572 (Direct) |
View |
| 2021-11-02 Tax Withholding |
2021-11-03 4:02 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Tommasi Ruben Chief Scientific Officer |
3,669 | $2.94 | 64,596 (Direct) |
View |
| 2021-10-19 Option Award |
2021-10-20 4:14 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Perros Manoussos See Remarks |
79,750 | $0 | 147,526 (Direct) |
View |
| 2021-10-19 Option Award |
2021-10-20 4:10 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Mueller John Patrick Chief Development Officer |
25,000 | $0 | 45,999 (Direct) |
View |
| 2021-10-19 Option Award |
2021-10-20 4:09 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Gutch Michael See Remarks |
25,000 | $0 | 46,241 (Direct) |
View |
| 2021-10-19 Option Award |
2021-10-20 4:08 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Tommasi Ruben Chief Scientific Officer |
25,000 | $0 | 68,265 (Direct) |
View |
| 2021-10-19 Option Award |
2021-10-20 4:08 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Keiley Elizabeth M General Counsel |
25,000 | $0 | 46,241 (Direct) |
View |
| 2021-10-19 Option Award |
2021-10-20 4:06 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Altarac David Chief Medical Officer |
25,000 | $0 | 46,241 (Direct) |
View |
| 2021-10-19 Option Award |
2021-10-20 4:05 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Ronsheim Matthew See Remarks |
25,000 | $0 | 46,241 (Direct) |
View |
| 2021-07-19 Option Award |
2021-07-20 4:06 pm |
N/A 2031-07-18 |
Entasis Therapeutics Holdings Inc. | ETTX | Triola Anna Diaz Chief Commercial Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-04-01 Option Award |
2021-04-02 10:36 am |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Mayer Howard Director |
22,000 | $0 | 22,000 (Direct) |
View |
| 2021-04-01 Option Award |
2021-04-02 10:35 am |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Behanna Heather Director |
22,000 | $0 | 22,000 (Direct) |
View |
| 2021-04-01 Option Award |
2021-04-02 10:34 am |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Meek David D. Director |
22,000 | $0 | 22,000 (Direct) |
View |
| 2021-04-01 Option Award |
2021-04-02 10:33 am |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | HASTINGS DAVID C Director |
22,000 | $0 | 22,000 (Direct) |
View |
| 2021-01-15 Option Award |
2021-01-19 4:10 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Tommasi Ruben Chief Scientific Officer |
25,000 | $0 | 47,024 (Direct) |
View |
| 2021-01-15 Option Award |
2021-01-19 4:09 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Gutch Michael CFO & CBO |
25,000 | $0 | 25,000 (Direct) |
View |
| 2021-01-15 Option Award |
2021-01-19 4:09 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Ronsheim Matthew See Remarks |
25,000 | $0 | 25,000 (Direct) |
View |
| 2021-01-15 Option Award |
2021-01-19 4:08 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Perros Manoussos President & CEO |
79,750 | $0 | 79,750 (Direct) |
View |
| 2021-01-15 Option Award |
2021-01-19 4:07 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Keiley Elizabeth M General Counsel |
25,000 | $0 | 25,000 (Direct) |
View |
| 2021-01-15 Option Award |
2021-01-19 4:06 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Altarac David Chief Medical Officer |
25,000 | $0 | 25,000 (Direct) |
View |
| 2021-01-15 Option Award |
2021-01-19 4:06 pm |
N/A N/A |
Entasis Therapeutics Holdings Inc. | ETTX | Mueller John Patrick Chief Development Officer |
25,000 | $0 | 25,000 (Direct) |
View |
| 2020-06-10 Option Award |
2020-10-06 4:33 pm |
N/A 2030-06-09 |
Entasis Therapeutics Holdings Inc. | ETTX | Meek David D. Director |
11,000 | $0 | 11,000 (Direct) |
View |
| 2020-06-10 Option Award |
2020-10-06 4:32 pm |
N/A 2030-06-09 |
Entasis Therapeutics Holdings Inc. | ETTX | HASTINGS DAVID C Director |
11,000 | $0 | 11,000 (Direct) |
View |
| 2020-06-10 Option Award |
2020-10-06 4:32 pm |
N/A 2030-06-09 |
Entasis Therapeutics Holdings Inc. | ETTX | Behanna Heather Director |
11,000 | $0 | 11,000 (Direct) |
View |
| 2020-06-10 Option Award |
2020-10-06 4:32 pm |
N/A 2030-06-09 |
Entasis Therapeutics Holdings Inc. | ETTX | Mayer Howard Director |
11,000 | $0 | 11,000 (Direct) |
View |
Ownership |
2020-09-11 4:33 pm |
N/A 2029-09-16 |
Entasis Therapeutics Holdings Inc. | ETTX | Ronsheim Matthew See Remarks |
0 | $0 | 95,000 (Direct) |
View |